Cantel Medical reported GAAP net income of $18,070,000, or $0.43 per diluted share, on a 16.8% increase in sales to $184,817,000 for the second quarter ended January 31, 2017. This compares with net income of $15,389,000, or $0.37 per diluted share, on sales of $158,271,000 for the second quarter ended January 31, 2016.
Cantel Medical announced that it entered into a definitive agreement to purchase its endoscopy business assets from Australian distributor, CR Kennedy & Company Pty Ltd.
Company celebrates 20th year of leadership in infection prevention.
The Company has expanded its direct sales operations in Canada by acquiring endoscope reprocessing business assets from its Canadian distributor, Vantage Endoscopy, Inc., a subsidiary of Diploma Canada Holdings Ltd.
Cantel Medical is a global company dedicated to delivering innovative infection prevention products and services for patients, caregivers, and other healthcare providers, which improve outcomes and help save lives. Through an expansive portfolio of endoscopy, water purification and filtration, and healthcare disposables, Cantel Medical provides high-quality infection prevention solutions and unsurpassed service, touching millions of patients each year around the world.